FSIS makes mad cow rule permanent

Jul 12, 2007

The U.S. Food Safety and Inspection Service announced a permanent prohibition on the slaughter of cattle that are unable to stand or walk.

The prohibition affects so-called downer cattle when they are presented for pre-slaughter inspection. FSIS officials said the inability to stand or walk can be a clinical sign of bovine spongiform encephalopathy, which is also called mad cow disease.

Under the rule announced Thursday, cattle that are injured after they pass pre-slaughter inspection will be re-evaluated to determine their eligibility for slaughter. Veal calves that cannot stand because they are tired or cold may be set apart and held for treatment and re-inspection.

The U.S. Department of Agriculture's FSIS rule, published in the July 13 Federal Register, makes permanent what had been an interim final rule prohibiting slaughter of non-ambulatory cattle in the United States. The final rule becomes effective Oct. 1.

Copyright 2007 by United Press International

Explore further: Face transplants change lives, identity

add to favorites email to friend print save as pdf

Related Stories

As numbers of gray seals rise, so do conflicts

4 hours ago

(AP)—Decades after gray seals were all but wiped out in New England waters, the population has rebounded so much that some frustrated residents are calling for a controlled hunt.

Recommended for you

Face transplants change lives, identity

5 hours ago

Patients are prepared to take significant risks in order to be considered for a face transplant, says Dr David Koppel, director of the largest craniofacial unit in the UK and Honorary Clinical Associate Professor ...

British Lords hold ten-hour debate on assisted dying

Jul 19, 2014

Members of Britain's unelected House of Lords spent almost ten hours on Friday discussing whether to legalise assisted dying, in an often emotional debate putting the question back on the agenda, if not on the statute books.

AbbVie, Shire agree on $55B combination

Jul 18, 2014

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.

User comments : 0